The Prototype: OpenAI And Retro Biosciences Made An AI Model For Bioengineering
Jan 17, 2025 - forbes.com
In this week's edition of The Prototype, several advancements in science and technology are highlighted. OpenAI and Retro Biosciences have developed a new AI model, GPT-4b, to engineer proteins that could improve treatments for conditions like blindness and diabetes. Blue Origin successfully launched its New Glenn rocket, although it failed to land the booster, while SpaceX's Starship test ended in an explosion. Researchers at the University of California, Santa Barbara, have created a photonic chip architecture using lasers for computation, potentially enhancing performance and reducing energy costs. Loft Orbital announced $170 million in funding to expand its standardized satellite infrastructure, and Surbhi Sarna launched Collate to automate research paperwork.
Additional updates include Brightline's bullet train project between Los Angeles and Las Vegas, California's investment in AI for wildfire detection, and a quantum signal transmission breakthrough in Tennessee. Innovations in vaccine storage and plastic recycling using mealworm larvae are also noted. The article concludes with a pro science tip on encouraging collaboration with IT departments and a recommendation for the series "Interior Chinatown" on Hulu.
Key takeaways:
OpenAI and Retro Biosciences have developed a new AI model, GPT-4b, to generate proteins for bioengineering, showing promise in cellular reprogramming.
Blue Origin successfully launched its New Glenn rocket, while SpaceX's Starship test resulted in an explosion during ascent.
Researchers at UC Santa Barbara have developed a new photonic chip architecture using lasers for computation, aiming for better performance and lower energy costs.
Loft Orbital raised $170 million to develop standardized satellite infrastructures, focusing on speed, reliability, and cost-effectiveness.
